These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37952392)

  • 1. Improved cerebrovascular reactivity mapping using coherence weighted general linear model in the frequency domain.
    Xu B; Vu C; Borzage M; González-Zacarías C; Shen J; Wood J
    Neuroimage; 2023 Dec; 284():120448. PubMed ID: 37952392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing end-tidal CO
    Zvolanek KM; Moia S; Dean JN; Stickland RC; Caballero-Gaudes C; Bright MG
    Neuroimage; 2023 May; 272():120038. PubMed ID: 36958618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular Reactivity Mapping Using Resting-State Functional MRI in Patients With Gliomas.
    Yeh MY; Chen HS; Hou P; Kumar VA; Johnson JM; Noll KR; Prabhu SS; Ferguson SD; Schomer DF; Peng HH; Liu HL
    J Magn Reson Imaging; 2022 Dec; 56(6):1863-1871. PubMed ID: 35396789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative mapping of cerebrovascular reactivity using resting-state BOLD fMRI: Validation in healthy adults.
    Golestani AM; Wei LL; Chen JJ
    Neuroimage; 2016 Sep; 138():147-163. PubMed ID: 27177763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CVR-MRICloud: An online processing tool for CO2-inhalation and resting-state cerebrovascular reactivity (CVR) MRI data.
    Liu P; Baker Z; Li Y; Li Y; Xu J; Park DC; Welch BG; Pinho M; Pillai JJ; Hillis AE; Mori S; Lu H
    PLoS One; 2022; 17(9):e0274220. PubMed ID: 36170233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of baseline CO
    van Niftrik CHB; Piccirelli M; Bozinov O; Maldaner N; Strittmatter C; Pangalu A; Valavanis A; Regli L; Fierstra J
    Magn Reson Imaging; 2018 Jun; 49():123-130. PubMed ID: 29447850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the regional and cerebral depth-dependent BOLD cerebrovascular reactivity response at 7T.
    Bhogal AA; Philippens ME; Siero JC; Fisher JA; Petersen ET; Luijten PR; Hoogduin H
    Neuroimage; 2015 Jul; 114():239-48. PubMed ID: 25876215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance.
    Bright MG; Murphy K
    Neuroimage; 2013 Dec; 83():559-68. PubMed ID: 23845426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular Reactivity Mapping Using Resting-State BOLD Functional MRI in Healthy Adults and Patients with Moyamoya Disease.
    Liu P; Liu G; Pinho MC; Lin Z; Thomas BP; Rundle M; Park DC; Huang J; Welch BG; Lu H
    Radiology; 2021 May; 299(2):419-425. PubMed ID: 33687287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular reactivity mapping using intermittent breath modulation.
    Liu P; Xu C; Lin Z; Sur S; Li Y; Yasar S; Rosenberg P; Albert M; Lu H
    Neuroimage; 2020 Jul; 215():116787. PubMed ID: 32278094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-based cerebrovascular reactivity using transfer function analysis reveals temporal group differences between patients with sickle cell disease and healthy controls.
    Leung J; Duffin J; Fisher JA; Kassner A
    Neuroimage Clin; 2016; 12():624-630. PubMed ID: 27722086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine tuning breath-hold-based cerebrovascular reactivity analysis models.
    van Niftrik CH; Piccirelli M; Bozinov O; Pangalu A; Valavanis A; Regli L; Fierstra J
    Brain Behav; 2016 Feb; 6(2):e00426. PubMed ID: 27110448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-vendor and multisite evaluation of cerebrovascular reactivity mapping using hypercapnia challenge.
    Liu P; Jiang D; Albert M; Bauer CE; Caprihan A; Gold BT; Greenberg SM; Helmer KG; Jann K; Jicha G; Rodriguez P; Satizabal CL; Seshadri S; Singh H; Thompson JF; Wang DJJ; Lu H
    Neuroimage; 2021 Dec; 245():118754. PubMed ID: 34826595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between BOLD-based cerebrovascular reactivity (CVR) and end-tidal CO
    Hou X; Liu P; Li Y; Jiang D; De Vis JB; Lin Z; Sur S; Baker Z; Mao D; Ravi H; Rodrigue K; Albert M; Park DC; Lu H
    Neuroimage; 2020 Feb; 207():116365. PubMed ID: 31734432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical modification to a resting state fMRI protocol for improved characterization of cerebrovascular function.
    Stickland RC; Zvolanek KM; Moia S; Ayyagari A; Caballero-Gaudes C; Bright MG
    Neuroimage; 2021 Oct; 239():118306. PubMed ID: 34175427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular reactivity mapping without gas challenges.
    Liu P; Li Y; Pinho M; Park DC; Welch BG; Lu H
    Neuroimage; 2017 Feb; 146():320-326. PubMed ID: 27888058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The voxel-wise analysis of false negative fMRI activation in regions of provoked impaired cerebrovascular reactivity.
    van Niftrik CHB; Piccirelli M; Muscas G; Sebök M; Fisher JA; Bozinov O; Stippich C; Valavanis A; Regli L; Fierstra J
    PLoS One; 2019; 14(5):e0215294. PubMed ID: 31059517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular reactivity (CVR) MRI with CO2 challenge: A technical review.
    Liu P; De Vis JB; Lu H
    Neuroimage; 2019 Feb; 187():104-115. PubMed ID: 29574034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the dynamics of cerebrovascular reactivity to carbon dioxide in fMRI under task and resting-state conditions.
    Shams S; Prokopiou P; Esmaelbeigi A; Mitsis GD; Chen JJ
    Neuroimage; 2023 Jan; 265():119758. PubMed ID: 36442732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of cerebrovascular reactivity measures in children using BOLD MRI.
    Leung J; Kim JA; Kassner A
    J Magn Reson Imaging; 2016 May; 43(5):1191-5. PubMed ID: 26435493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.